Catalyst Pharmaceuticals Inc (NASDAQ: CPRX) is 41.42% higher on its value in year-to-date trading and has touched a low of $15.26 and a high of $26.58 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CPRX stock was last observed hovering at around $21.62 in the last trading session, with the day’s gains setting it 0.23%.
Currently trading at $21.85, the stock is -1.97% and -7.34% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.0 million and changing 1.04% at the moment leaves the stock -2.46% off its SMA200. CPRX registered 4.70% gain for a year compared to 6-month gain of 8.22%. The firm has a 50-day simple moving average (SMA 50) of $23.5816 and a 200-day simple moving average (SMA200) of $22.4004.
The stock witnessed a -15.44% loss in the last 1 month and extending the period to 3 months gives it a 2.10%, and is 1.86% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 3.14% over the week and 3.20% over the month.
Catalyst Pharmaceuticals Inc (CPRX) has around 181 employees, a market worth around $2.67B and $534.65M in sales. Current P/E ratio is 13.94 and Fwd P/E is 12.40. Profit margin for the company is 36.91%. Distance from 52-week low is 43.18% and -17.80% from its 52-week high. The company has generated returns on investments over the last 12 months (24.76%).
The EPS is expected to grow by 14.20% this year
505.0 institutions hold shares in Catalyst Pharmaceuticals Inc (CPRX), with institutional investors hold 88.69% of the company’s shares. The shares outstanding are 121.96M, and float is at 111.11M with Short Float at 6.96%. Institutions hold 83.18% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 18.69 million shares valued at $289.58 million. The investor’s holdings represent 15.819 of the CPRX Shares outstanding. As of 2024-06-30, the second largest holder is DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) with 9.13 million shares valued at $141.38 million to account for 7.7232 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 8.1 million shares representing 6.8542 and valued at over $125.47 million, while STATE STREET CORP holds 5.1052 of the shares totaling 6.03 million with a market value of $93.46 million.
Catalyst Pharmaceuticals Inc (CPRX) Insider Activity
The most recent transaction is an insider sale by Sundaram Preethi, the company’s Chief Strategy Officer. SEC filings show that Sundaram Preethi sold 2,324 shares of the company’s common stock on Jun 10 ’25 at a price of $26.41 per share for a total of $61377.0. Following the sale, the insider now owns 42681.0 shares.
Catalyst Pharmaceuticals Inc disclosed in a document filed with the SEC on Jun 11 ’25 that Sundaram Preethi (Chief Strategy Officer) sold a total of 1,600 shares of the company’s common stock. The trade occurred on Jun 11 ’25 and was made at $26.42 per share for $42272.0. Following the transaction, the insider now directly holds 41081.0 shares of the CPRX stock.
